AI-generated summary
The authors reviewed 25 selected animal studies, following PRISMA guidance, on photobiomodulation (low-level laser or LED light) used to improve skin flap viability. They report that about 90% of studies measuring outcomes found smaller necrotic areas after treatment, with similar improvement reported for LED and laser. The included evidence comes from animal models only.
- Studies included
- 25
- Who or what was studied
- Animal models with skin flap surgery
- Limits stated in the abstract
- All included studies are animal studies, and the abstract reports considerable variation in laser parameters across them.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review, Light-emitting diode, Laser, Angiogenesis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.